Home>
US Stocks>
Fulcrum Therapeutics Inc

Fulcrum Therapeutics Inc share price today

(FULC)

Fulcrum Therapeutics Inc share price is $3.83 & ₹324.18 as on 6 Dec 2024, 2.30 'hrs' IST

$3.83

▲

0.32

(9.12%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Fulcrum Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Fulcrum Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Fulcrum Therapeutics Inc. Get details on the Indian mutual funds that are investing in Fulcrum Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Fulcrum Therapeutics Inc's financials.

Fulcrum Therapeutics Inc share price movements

$3.48
$3.91
$3.83
9.14%
Downside
Day's Volatility :10.88%
Upside
1.92%
$2.86
$13.70
$3.83
25.33%
Downside
52 Weeks Volatility :79.12%
Upside
72.04%

Fulcrum Therapeutics Inc Returns

Period	Fulcrum Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-55.15%	-5.7%	0.0%
6 Months	-53.8%	-0.8%	0.0%
1 Year	-22.78%	9.9%	0.0%
3 Years	-75.05%	10.7%	-19.7%

Fulcrum Therapeutics Inc Key Statistics

in dollars & INR

Previous Close	$3.51
Open	$3.49
Today's High	$3.905
Today's Low	$3.48
Market Capitalization	$206.6M
Today's Volume	$1.2M
52 Week High	$13.7
52 Week Low	$2.86
Revenue TTM	$81.6M
EBITDA	$-30.9M
Earnings Per Share (EPS)	$-0.32
Profit Margin	-24.79%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-7.37%

How to invest in Fulcrum Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Fulcrum Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Fulcrum Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Fulcrum Therapeutics Inc or FULC on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Fulcrum Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Fulcrum Therapeutics Inc shares which would translate to 0.221 fractional shares of Fulcrum Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Fulcrum Therapeutics Inc

211%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Fulcrum Therapeutics Inc on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 211% more investors are searching Fulcrum Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Fulcrum Therapeutics Inc

RA Capital Management, LLC
18.96%
TCG Crossover Management, LLC
9.73%
BlackRock Inc
8.90%
Nantahala Capital Management, LLC
8.86%
Vanguard Group Inc
6.07%
TRV GP IV, LLC
4.34%

Analyst Recommendation on Fulcrum Therapeutics Inc

Buy

78%Buy

14%Hold

7%Sell

Based on 14 Wall street analysts offering stock ratings for Fulcrum Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Fulcrum Therapeutics Inc

What analysts predicted

Upside of 38.01%

Current:

$3.83

Target:

$5.29

Insights on Fulcrum Therapeutics Inc

Increasing Revenue
Revenue is up for the last 3 quarters, 759.0K → 80.0M (in $), with an average increase of 55.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 55.40M → -21.69M (in $), with an average decrease of 139.2% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 43.9% return, outperforming this stock by 61.2%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 115.7%

Fulcrum Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Fulcrum Therapeutics Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Fulcrum Therapeutics Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Fulcrum Therapeutics Inc	11.66%	-53.8%	-22.78%	-75.05%	-69.01%
Regeneron Pharmaceuticals, Inc.	-5.97%	-23.44%	-9.57%	20.91%	110.02%
Biontech Se	11.44%	18.44%	16.6%	-60.74%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.77%	64.82%	42.06%	39.68%	108.61%
Vertex Pharmaceuticals Incorporated	-6.83%	-4.79%	29.94%	124.11%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Fulcrum Therapeutics Inc	NA	NA	NA	-0.15	-0.07	-0.07	NA	3.8
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Fulcrum Therapeutics Inc	Buy	$206.6M	-69.01%	NA	-24.79%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Fulcrum Therapeutics Inc

what if we could regulate genes, not just discover them? what if we could treat disease at their genetic source? what if we could integrate multiple disciplines to develop breakthrough medicines? what if you could be a part of a passionate team committed to the patients we serve? we can. we will. we are. join us. we are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. a fulcrum is defined as the point on which a lever rests, balances and pivots. fulcrum therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. the fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. our approach the sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome – gene regulation. the fulcrum product eng

Organization	Fulcrum Therapeutics Inc
Employees	76
CEO	Mr. Alexander C. Sapir
Industry	Health Technology

Management People of Fulcrum Therapeutics Inc

Name	Title
Mr. Alexander C. Sapir	CEO, President & Director
Mr. Alan A. Musso C.M.A., CPA	Chief Financial Officer
Mr. Curtis G. Oltmans J.D.	Senior VP, Chief Legal Officer & Corporate Secretary
Mr. Mel Hayes	Executive Vice President of Patient Experience
Dr. Bradley E. Bernstein M.D., Ph.D.	Founder
Dr. Michael R. Green	Founder
Dr. Rudolf Jaenisch M.D., Ph.D.	Founder
Dr. Tsun-Huei Lee M.D., Ph.D.	Founder
Dr. Danny Reinberg	Founder
Mr. Gregory Tourangeau	Controller & Principal Accounting Officer

Important FAQs about investing in Fulcrum Therapeutics Inc from India :

What is Fulcrum Therapeutics Inc share price today?

Fulcrum Therapeutics Inc (FULC) share price today is $3.83.

Can Indians buy Fulcrum Therapeutics Inc shares?

Yes, Indians can invest in the Fulcrum Therapeutics Inc (FULC) from India.

With INDmoney, you can buy Fulcrum Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Fulcrum Therapeutics Inc at zero transaction cost.

How can I buy Fulcrum Therapeutics Inc shares from India?

It is very easy to buy Fulcrum Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Fulcrum Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Fulcrum Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Fulcrum Therapeutics Inc stocks?

To start investing in Fulcrum Therapeutics Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.